| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Maria Giovanna Francipane | Q63412198 |
| Jan Paul Medema | Q89296672 | ||
| Matilde Todaro | Q90524639 | ||
| Giorgio Stassi | Q5563510 | ||
| P2860 | cites work | The genomic landscapes of human breast and colorectal cancers | Q27861078 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 2151-2162 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Colon cancer stem cells: promise of targeted therapy | |
| P478 | volume | 138 |
| Q33851929 | (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway |
| Q27301073 | A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling |
| Q38761269 | A Study on the Mechanism of Low-Expressed Cancer Stem Cell Marker Lgr5 in Inhibition of the Proliferation and Invasion of Colorectal Carcinoma |
| Q35801362 | A concise review on the current understanding of pancreatic cancer stem cells |
| Q33999947 | A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. |
| Q41484437 | A mouse model of the most aggressive subgroup of human medulloblastoma |
| Q33838881 | AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors |
| Q92965718 | ALKATI interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma |
| Q37451822 | AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer. |
| Q47841672 | Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer. |
| Q39038772 | Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts |
| Q34499893 | Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model |
| Q35748841 | B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells |
| Q91611020 | Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer |
| Q41636889 | Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer |
| Q41661065 | Bromopropane Compounds Increase the Stemness of Colorectal Cancer Cells. |
| Q38035206 | CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges |
| Q37990005 | CD133 as a target for colon cancer |
| Q54967460 | CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma. |
| Q34640685 | CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy |
| Q33908271 | CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres |
| Q38922806 | CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? |
| Q36176043 | CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice |
| Q51317510 | CD24 is expressed in gastric parietal cells and regulates apoptosis and the response to Helicobacter felis infection in the murine stomach. |
| Q37831812 | CD44 in hematological neoplasias |
| Q38748287 | CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells |
| Q39004664 | CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer |
| Q89701178 | CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer |
| Q26765342 | Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies |
| Q36737189 | Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes |
| Q29616694 | Cancer drug resistance: an evolving paradigm |
| Q26775475 | Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate |
| Q42540118 | Cancer stem cell and stromal microenvironment |
| Q55122201 | Cancer stem cells as key drivers of tumour progression. |
| Q57150975 | Cancer stem cells in progression of colorectal cancer |
| Q86523719 | Cancer stem cells: the challenges ahead |
| Q27026428 | Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer |
| Q40442766 | Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer |
| Q45308046 | Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients. |
| Q36225000 | Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients |
| Q36871965 | Colon cancer stem cells: controversies and perspectives |
| Q37825224 | Colon cancer stem cells: implications in carcinogenesis |
| Q33836972 | Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia |
| Q37974613 | Colorectal cancer stem cells |
| Q38161357 | Colorectal cancer stem cells and cell death |
| Q39767253 | Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target |
| Q38899681 | Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas |
| Q37431637 | Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures |
| Q28543093 | Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT |
| Q33896515 | Curcumin: An age-old anti-inflammatory and anti-neoplastic agent |
| Q41843301 | DCLK1 immunoreactivity in colorectal neoplasia. |
| Q42679134 | Dclk1 distinguishes between tumor and normal stem cells in the intestine |
| Q42040567 | Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells |
| Q38322466 | Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells |
| Q49833366 | Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes |
| Q36957616 | Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells |
| Q38891257 | Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view |
| Q38038526 | Dynamic regulation of cancer stem cells and clinical challenges |
| Q38747818 | Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells. |
| Q42791305 | Effect of ageing on colonic mucosal regeneration |
| Q38705707 | Endothelial cells activate the cancer stem cell-associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion |
| Q36411034 | EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer |
| Q37085982 | Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer |
| Q42409031 | Epigenetic control of epithelial-mesenchymal-transition in human cancer |
| Q33700204 | Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer |
| Q35939812 | Eugenia jambolana (Java Plum) Fruit Extract Exhibits Anti-Cancer Activity against Early Stage Human HCT-116 Colon Cancer Cells and Colon Cancer Stem Cells. |
| Q44399864 | Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy |
| Q38962257 | Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors |
| Q34572166 | Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin |
| Q46154143 | Expression of OV-6 in primary colorectal cancer and rectal cancer with preoperative chemoradiotherapy: a clinicopathological study |
| Q36297343 | Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. |
| Q36305374 | Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. |
| Q96428032 | Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK |
| Q41280295 | FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells |
| Q58784171 | Fenretinide targeting of human colon cancer sphere cells through cell cycle regulation and stress-responsive activities |
| Q26849278 | Frizzled7 as an emerging target for cancer therapy |
| Q57470958 | GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma |
| Q50201405 | Genistein regulates tumor microenvironment and exhibits anticancer effect in dimethyl hydrazine-induced experimental colon carcinogenesis |
| Q33855045 | Genotypic and phenotypic characterization of side population of gastric cancer cell lines |
| Q36099347 | Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis |
| Q52593750 | Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture. |
| Q46781624 | Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease |
| Q51736765 | ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance. |
| Q46461134 | Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer |
| Q39474693 | Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line |
| Q46080136 | In situ validation of an intestinal stem cell signature in colorectal cancer |
| Q83754268 | Increased CD133 expression after preoperative chemoradiotherapy in rectal cancers other than mucin-rich tumors |
| Q36872765 | Increased growth of colorectal liver metastasis following partial hepatectomy |
| Q27320228 | Induction of cancer stem cell properties in colon cancer cells by defined factors |
| Q36569707 | Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles |
| Q91810259 | Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells |
| Q64996870 | Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. |
| Q38087571 | Intestinal stem cells - types and markers |
| Q38192621 | Intestinal stem cells and the colorectal cancer microenvironment |
| Q36627895 | Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance |
| Q37636537 | Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery |
| Q99414140 | Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition |
| Q89997751 | LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma |
| Q21560941 | LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines |
| Q35030903 | Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging. |
| Q47729757 | Logarithmic expansion of LGR5+ cells in human colorectal cancer. |
| Q35238078 | Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling |
| Q92966476 | METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma |
| Q47224069 | Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway. |
| Q36708808 | Major Protein of Carcinoembryonic Antigen Gene Family - CD66c, A Novel Marker in Colon Carcinoma |
| Q37890251 | Microenvironmental regulation of stem cells in intestinal homeostasis and cancer |
| Q54977795 | Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis. |
| Q37839545 | Molecular identification and targeting of colorectal cancer stem cells |
| Q38953543 | Molecular pathways driving disease-specific alterations of intestinal epithelial cells |
| Q44913105 | Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer |
| Q64069928 | Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation |
| Q55059103 | Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression. |
| Q33708609 | Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells |
| Q35666438 | Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway. |
| Q49988786 | Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. |
| Q41342397 | NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations. |
| Q41389518 | Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division |
| Q84968317 | New insight into cancer therapeutics: Induction of differentiation by regulating the Musashi/Numb/Notch pathway |
| Q37627063 | Nodal promotes the self-renewal of human colon cancer stem cells via an autocrine manner through Smad2/3 signaling pathway |
| Q38940597 | Non-coding RNAs Functioning in Colorectal Cancer Stem Cells |
| Q51256623 | Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling. |
| Q37699339 | Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer |
| Q39252472 | Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity |
| Q37326861 | Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression |
| Q86478397 | Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers |
| Q38793207 | Procaine Inhibits Proliferation and Migration of Colon Cancer Cells Through Inactivation of the ERK/MAPK/FAK Pathways By Regulation of RhoA. |
| Q33918070 | Prognostic significance of CD44 variant 2 upregulation in colorectal cancer |
| Q36642164 | Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients |
| Q35305771 | Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis |
| Q34936453 | Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis |
| Q55461475 | Prognostic value of Musashi-1 in gliomas. |
| Q40668131 | Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis |
| Q34637735 | Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review |
| Q54339982 | Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. |
| Q35172957 | RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells |
| Q47836030 | RNA binding protein Musashi-2 regulates PIWIL1 and TBX1 in mouse spermatogenesis. |
| Q39281785 | Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo |
| Q35772157 | Regulation of colon cancer recurrence and development of therapeutic strategies |
| Q90009252 | Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells |
| Q36897112 | Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study |
| Q36677847 | Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells |
| Q41479717 | SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer |
| Q35723100 | Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo |
| Q42381878 | Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells. |
| Q45778366 | Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer |
| Q36185358 | Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer |
| Q36215252 | Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells. |
| Q34351577 | Specificity factors in cytoplasmic polyadenylation |
| Q28076017 | Stem cell dynamics and pretumor progression in the intestinal tract |
| Q37807169 | Stem cells and colon cancer: The questionable cancer stem cell hypothesis |
| Q37777341 | Stem cells in colon cancer. A new era in cancer theory begins |
| Q26823217 | Stem cells, colorectal cancer and cancer stem cell markers correlations |
| Q83379077 | Stemming a tumor with a little miR |
| Q34717467 | Strong expression of CD133 is associated with increased cholangiocarcinoma progression |
| Q52671384 | Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells. |
| Q64074399 | TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer |
| Q37223261 | TNIK inhibition abrogates colorectal cancer stemness |
| Q41912339 | Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers. |
| Q49860324 | Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors |
| Q38889490 | Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways |
| Q35125616 | Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. |
| Q26784365 | Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy |
| Q92956349 | Targeting oxidative pentose phosphate pathway prevents recurrence in mutant Kras colorectal carcinomas |
| Q37993393 | Targeting the vasculature of visceral tumors: novel insights and treatment perspectives |
| Q61813468 | Tea Polyphenols in Promotion of Human Health |
| Q41233333 | Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence |
| Q92572796 | Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma |
| Q49658179 | The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer |
| Q37058165 | The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development |
| Q97074390 | The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication |
| Q37980960 | The developing cancer stem-cell model: clinical challenges and opportunities |
| Q38963031 | The impact of inflammatory lipid mediators on colon cancer-initiating cells |
| Q36545318 | The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44. |
| Q42164554 | The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models |
| Q35828678 | The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers |
| Q41181813 | The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies. |
| Q37841141 | The role of colorectal cancer stem cells in metastatic disease and therapeutic response |
| Q38015703 | The role of epigenetic regulation in stem cell and cancer biology |
| Q21560986 | The spatial distribution of LGR5+ cells correlates with gastric cancer progression |
| Q39097271 | Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress |
| Q26778983 | Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer |
| Q98613147 | Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells |
| Q45204638 | Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines |
| Q38794655 | Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models |
| Q40745223 | Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio. |
| Q41916350 | Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells? |
| Q46238868 | Tumor-derived exosomes in colorectal cancer progression and their clinical applications |
| Q57193567 | WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma |
| Q37133124 | Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness |
| Q44576680 | Wnt and BMP signals control intestinal adenoma cell fates |
| Q64245310 | YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma |
| Q39561847 | Zebrafish models of rhabdomyosarcoma |
| Q37307220 | Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress. |
| Q33977008 | β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells |
Search more.